EMCDDA Home
  • EN
Search

Table TDI-24. Type of treatment centre by primary drug of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) New clients by country and primary drug and type of treatment centre (%)

CountryOpioidsCocaineCannabisAmphetaminesEcstasy
OutpatientInpatientOthersTotalOutpatientInpatientOthersTotalOutpatientInpatientOthersTotalOutpatientInpatientOthersTotalOutpatientInpatientOthersTotal
Belgium86.713.3:52891.88.2:52795.34.7:147390.99.1:37591.38.7:46
Bulgaria53.846.2:346::::71.428.6:776.923.1:13::::
Czech Republic 34.125.840.163337.520.841.72440.920.139.079015.722.561.8262820.0:80.05
Denmark94.55.5:19997.22.8:10697.52.5:110095.14.9:206100.0::10
Germany(1)86.79.24.1304789.48.71.9115596.32.70.9912391.05.03.91607::::
Estonia(2)100.0::139:::0100.0::6100.0::10::::
Ireland61.011.627.4152364.512.722.751963.320.716.0110686.49.14.52270.016.014.050
Greece55.533.710.9206363.233.33.411784.314.11.6382100.0::1::::
Spain(3)100.0::4070100.0::12847100.0::5058100.0::237100.0::110
France96.8:2.8249690.8:9.260795.0:5.06756100.0::17100.0::16
Italy100.0::13387100.0::10020100.0::6029100.0::31100.0::76
Cyprus84.712.92.412477.811.111.15496.90.82.3128100.0::1::::
Latvia100.0::175100.0::3100.0::94100.0::137100.0::1
Lithuania(4)100.0::254::::100.0::7100.0:15::::
Luxembourg::::::::::::::::::::
Hungary81.64.613.88793.83.13.16598.40.41.2228194.20.75.127792.9:7.128
Malta(5)100.0::114100.0::76100.0::48::::100.0::4
Netherlands(6)92.57.5:49189.710.3:166093.46.6:312092.17.9:37890.99.1:33
Austria82.817.2:81883.616.4:12297.72.3:61995.14.9:4180.020.0:5
Poland(7)100.0::112100.0::19100.0::399100.0::218100.0::11
Portugal100.0::2891100.0::449100.0::604100.0::2100.0::4
Romania52.146.31.670692.37.7:1361.338.7:93:100.0:350.050.0:2
Slovenia100.0::298100.0::18100.0::47100.0::3100.0::1
Slovakia45.424.630.024085.714.3:743.228.028.823649.832.218.0283100.0::2
Finland63.436.6:112::::68.331.7:10163.236.8:57::::
Sweden(8)48.151.9:34146.653.4:5875.524.5:64241.558.5:30633.366.7:9
United Kingdom 92.73.93.31789297.61.80.5950399.20.30.51221496.81.61.6164099.3:0.7268
Croatia88.311.7:66792.27.8:5194.45.6:49898.02.0:49100.0::6
Turkey:100.0:771:100.0:38:100.0:445:::::100.0:22
Norway::::::::::::::::::::
Total89.57.23.35452497.41.80.73805894.63.42.05340666.612.620.8855791.66.32.1709

Notes:

 : Indicates no data are available                                           

 For details on type of treatment centres reported other than outpatient and inpatient treatment centres see Table TDI-7 

 Percentages are of known total of cases.                                           

 (1) Amphetamines data refer to all stimulants                                           

 (2) Data refers to outpatient and inpatient treatment centres (aggregated data).                                           

 (3) Last data available refer to 2008. Outpatient centres also includes treatment units in prisons (aggregated data). 

 (4) Amphetamines data refer to all stimulants 

 (5) Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).                                           

 (6) Outpatient data refer to outpatient centres, inpatient centres and low-threshold agencies (aggregated data).                                           

 (7) Data refers to 2008 and to 33 health care units.                                           

 (8) Data on new clients are not available for treatment units in prison.                                           

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI Fonte tables. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 30 June 2011